Avance Clinical is the largest full-service Australian CRO - now with US operations - specializing in delivering quality clinical trials, with globally accepted data, for international biotechs. Avance Clinical, a Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient, has been providing CRO services in the region for the past 24 years. The company’s clients are biotechs in their early phases of drug development that need fast, agile, and adaptive solution-oriented clinical research services. Avance Clinical offers pre-clinical services with their experienced ClinicReady team right through to Phases 1 and 2 leveraging significant Government incentive rebates of up to 43.5% and rapid start-up regulatory processes. With experience across more than 105 indications the CRO can deliver world-class results and high-quality internationally accepted data for FDA and EMA review. Avance Clinical delivers customised solutions designed around specific client needs rather than a one size fits all approach. As a company, Avance Clinical has focused on state-of-the-art technology and systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, and Medrio are just some of Avance Clinical’s trusted technology partners. Visit http://www.avancecro.com for more information. Recent Awards: Excellence in Business Award 2021 Frost & Sullivan Asia-Pacific CRO Market Leadership Award 2020 Frost & Sullivan Asia-Pacific Customer Value Leadership Award 2021